Two Medical Companies Announce Deal To Develop This Innovative Drug

ABVC BioPharma Enters Global Licensing Agreement for CNS Drugs: What This Means for You.

ABVC BioPharma, a clinical-stage biopharmaceutical company, has announced a crucial step forward in its mission to develop innovative therapies for neurological disorders. The company has entered into a legally binding term sheet for a multi-year global licensing agreement with AiBtl BioPharma. This groundbreaking deal encompasses the clinical trial, re…